

| Salt Composition: | Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (15mg) |
| Manufacturer: | Franco-Indian Pharmaceuticals Pvt Ltd |
| Storage: | Below 25 degree celcius |
Out of Stock
Have doubts about this medicine?
Have doubts about this medicine?
Glyciphage-PG 1 Tablet SR is a combination medicine used to control blood sugar levels in adults with type 2 diabetes mellitus. Glyciphage-PG 1 Tablet SR is a combination medicine that helps control blood sugar levels in adults with type 2 diabetes mellitus. It is used together with diet and exercise to improve blood sugar control. The medicine helps in the proper utilization of insulin, thereby lowering blood sugar levels. It is important to follow the prescribed dosage and be aware of potential side effects and warnings, including those related to pregnancy, breastfeeding, and alcohol consumption.
Glyciphage-PG 1 Tablet SR is a combination of three antidiabetic medicines: Glimepiride, Metformin, and Pioglitazone. They work by different mechanisms to provide better control of blood sugar when single or dual therapy is not effective. Glimepiride increases the amount of insulin released by the pancreas. Metformin lowers glucose production in the liver, delays glucose absorption from the intestines, and increases the body's sensitivity to insulin. Pioglitazone further increases insulin sensitivity.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush, or break it. Glyciphage-PG 1 Tablet SR is to be taken with food.
Alcohol
It is unsafe to consume alcohol with Glyciphage-PG 1 Tablet SR.
Breastfeed
Glyciphage-PG 1 Tablet SR is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Pregnancy
Glyciphage-PG 1 Tablet SR may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Please consult your doctor.